Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


Pre-Filled Syringes Americas

31 Mar 2014 - 01 Apr 2014 - Iselin, NJ, USA



Bookmark and Share


Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

The importance of pre-filled syringes and injection devices have never been more pertinent, especially in the US. The challenges of finding a delivery method with patient centric design that avoids leaching, requires swift and decisive decisions early in the development process to avoid unnecessary costs and delays in development.

The SMi Group announces its Pre-Filled Syringes America Conference will be taking place in Iselin, New Jersey, USA, on the 31st March – 1st April 2014, where solutions to these challenges will be offered by many of the leading names in pharmaceuticals and medical device technologies.

Event’s website: http://www.smi-online.co.uk/2014pfs-usa30.asp  

Registration is now open. Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

Benefits of attending:

• 3 days of presentations, panel discussions and an interactive workshop. Return to your business with the information and contacts to make the

right decisions for your products

• Focus sessions on biologics, manufacturing, polymers and extractables and leachables

• 20+ expert speakers from throughout the PFS and device ecosystem

• 85+ key decision makers, influencers and innovation drivers attending from the most relevant and sought after organisations in pre-filled syringes

• Network with delegates from the leading Biotechnology and Pharmaceutical businesses globally during the series of networking breaks, lunches and networking evenings designed to help conversation flow

• Hands on exhibition to help you evaluate the leading solutions in the marketplace and meet the thought leaders who developed them 

Key speakers include:

• Scott Brown, Device Development Lead, Merck 

• Alexei Goraltchouk, Senior Manager, Operations, Regeneron

• Stephen Barat, Senior Director, Toxicology and Operations, Forest Laboratories

• Steven Projan, SVP, MedImmune*

• Martin Dearden, Chief Corporate Microbiologist, UCB

• Thomas Osterberg, Senior Manager, Biologics, Pfizer Inc

• Greg Sacha, Senior Research Scientist, Baxter

• Christian Siegmund, Head of Prefilled Syringes and Liquid Vials, Roche

• Ravi S. Harapanhalli, Vice President, ParExel, and Former FDA Senior Executive

and many others.

For further information please contact Fateja Begum on +44 (0)20 7827 6184 or email: pharma@smiconferences.co.uk




Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!